LIBTAYO FDA approval across Multiple indications

When:  Feb 17, 2026 from 18:00 to 20:00 (ET)
Associated with  Central New Jersey

February CNJONS and Monmouth County Oncology combined Dinner Meeting

Latest Data for LIBTAYO®(cemiplimab-rwlc) FDA approved across Multiple Indications

Tuesday, February 17, 2026

Registration: 5:30pm; Program begins at 6:00pm

Charlie’s of Lincroft

700 Newman Springs Road, Lincroft, NJ 07738

RSVP by 2/13/26 to Raven Owen at Regeneron: raven.owen@regeneron.com or 929-313-0746, please use meeting ID: RGN0041151 when RSVPing

Location

Charlie's of Lincroft
700 Newman Springs Road
Lincroft, NJ 07738

Contact

Raven Owen
929-313-0746
raven.owen@regeneron.com